Catalyst Health Ventures
Boston, Massachusettschv.vc
Overview
Catalyst Health Ventures (CHV) is an early-stage venture capital firm that invests in transformative medical technologies. The firm focuses on therapeutic medical devices, diagnostics, and digital health, aiming to address unmet global healthcare needs. CHV typically partners with companies from the seed to Series B stages, often acting as the first institutional investor, and provides hands-on guidance and collaborative support to its portfolio companies.
Portfolio Companies
11
Website
chv.vcInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AtaCor Medical | Oct 2025 | Growth Equity | Co-investor |
| Venova Medical, Inc. | Sep 2024 | Series B | Lead |
| Brixton Biosciences | May 2024 | Series B | Co-investor |
| AtaCor Medical | Apr 2024 | Series C | Co-investor |
| Avive | Apr 2024 | Series B | Lead |
Key People
Joshua Phillips
Managing General Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.